Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MXCT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
14 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
123 filers reported a long position in MXCT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Capricorn Fund Managers Ltd | $10.1M | 8.2M | Unchanged |
| Vitruvian Partners LLP | $6.2M | 5M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $5M | 4M | +1.2% |
| MORGAN STANLEY | $4.5M | 3.7M | +0.2% |
| Mudita Advisors LLP | $4.1M | 3.4M | Unchanged |
| BlackRock, Inc. | $3.8M | 3.1M | -65.2% |
| Brooklands Fund Management Ltd | $3.7M | 2.8M | +30% |
| BNP Paribas Asset Management Holding S.A. | $3.4M | 2.8M | Unchanged |
| CADIAN CAPITAL MANAGEMENT, LP | $2.7M | 2.2M | +27.8% |
| Peapod Lane Capital LLC | $2.6M | 2.1M | +59.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.